tungsten has been researched along with Acquired Immunodeficiency Syndrome in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirsch, MS; Kaplan, JC | 1 |
| Buimovici-Klein, E; Cooper, LZ; Englard, A; Grieco, MH; Lange, M; McKinley, GF; Ong, KR; Reddy, M | 1 |
| Barre-Sinoussi, F; Chermann, JC; Vittecoq, D; Woerle, R | 1 |
| Aymard, JP; Ferry, R; Janot, C; Legras, B; May, T; Schooneman, F; Streiff, F | 1 |
| Kaplan, JC; Sandström, EG | 1 |
| Broder, S; Yarchoan, R | 1 |
| Barre-Sinoussi, F; Chermann, JC; Dormont, D; Gentilini, M; Griscelli, C; Montagnier, L; Rozenbaum, W; Spire, B; Vilmer, E | 1 |
| Sandström, E | 1 |
| Weber, J | 1 |
| Fauci, AS; Lane, HC | 1 |
| Marwick, C; Riesenberg, DE | 1 |
| Moskovitz, BL | 1 |
| Rada, B | 1 |
| Castagna, A; Crocchiolo, P; Lazzarin, A; Moroni, M; Orlando, G; Verani, P | 1 |
6 review(s) available for tungsten and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Prospects of therapy for infections with human T-lymphotropic virus type III.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antimony; Antiviral Agents; Combined Modality Therapy; Deltaretrovirus; Foscarnet; Humans; Immunotherapy; Interferons; Lactams, Macrocyclic; Phosphonoacetic Acid; Receptors, Virus; Reverse Transcriptase Inhibitors; Ribavirin; RNA Processing, Post-Transcriptional; RNA, Viral; Suramin; Tungsten; Tungsten Compounds; Virus Replication | 1985 |
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Forecasting; Foscarnet; Immunotherapy; Phosphonoacetic Acid; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1987 |
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1987 |
Antiviral drugs for AIDS. Current status and future prospects.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1986 |
Immunologic reconstitution in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Antimony; Antiviral Agents; Bone Marrow Transplantation; Deltaretrovirus; Humans; Immunotherapy; Interferon Type I; Interferon-gamma; Interleukin-2; Lymphocyte Transfusion; Ribavirin; Suramin; Thymus Gland; Tungsten; Tungsten Compounds | 1985 |
[Experimental chemotherapy of AIDS].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antimony; Antiviral Agents; Humans; Oligopeptides; Peptide T; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1988 |
1 trial(s) available for tungsten and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antimony; Antiviral Agents; Aspartate Aminotransferases; Blood Cell Count; Clinical Trials as Topic; Drug Tolerance; Humans; Male; Platelet Count; T-Lymphocytes; Tungsten; Tungsten Compounds | 1988 |
7 other study(ies) available for tungsten and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Reverse transcriptase activity (RTA) in lymphocyte cultures of AIDS patients treated with HPA-23.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antimony; Antiviral Agents; Drug Evaluation; Humans; Lymphocytes; Male; Middle Aged; RNA-Directed DNA Polymerase; Tungsten; Tungsten Compounds | 1986 |
Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Cells, Cultured; Half-Life; Humans; Lymphocytes; RNA-Directed DNA Polymerase; Thrombocytopenia; Time Factors; Tungsten; Tungsten Compounds | 1988 |
Toxicity of HPA-23 (ammonium-21-tungsto-9-antimoniate) for normal human myeloid progenitor cells (GM-CFU) in vitro.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Antimony; Antiviral Agents; Child; Dose-Response Relationship, Drug; Female; Granulocytes; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Tungsten; Tungsten Compounds | 1989 |
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antimony; Deltaretrovirus; Female; Humans; Male; Tungsten; Tungsten Compounds | 1985 |
AIDS: the virus, antivirals and vaccines.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Genes, Viral; HIV; Humans; Phosphonoacetic Acid; Suramin; Thymidine; Tungsten; Tungsten Compounds; Viral Vaccines; Virus Replication; Zidovudine | 1987 |
Anti-AIDS agents show varying early results in vitro and in vivo.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Deltaretrovirus; Humans; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1985 |
Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antimony; Antiviral Agents; Humans; Interferon Type I; Ribavirin; Ribonucleosides; Tungsten; Tungsten Compounds | 1987 |